Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference

LONDON--(BUSINESS WIRE)-- Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced that management will present a company overview at the Leerink Partners Global Healthcare Conference on Wednesday, March 12^th at 1:00 p.m. ET.

The live webcast can be accessed via the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be available following the conference.

About Silence Therapeutics

Silence Therapeutics is a global clinical-stage biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines created with proprietary siRNA (short interfering RNA) technology. Silence leverages its mRNAi GOLD™ platform to create innovative siRNAs designed to precisely target and silence disease-associated genes in the liver, which represents a substantial opportunity. Silence focuses on areas of high unmet medical need with programs advancing in cardiovascular disease, hematology and rare diseases. For more information, please visit https://www.silence-therapeutics.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250305330507/en/

Inquiries:



Silence Therapeutics plc

Gem Hopkins, VP, Head of IR and Corporate Communications

ir@silence-therapeutics.com

Tel: +1 (646) 637-3208

Source: Silence Therapeutics plc

FAQ

When is Silence Therapeutics (SLN) presenting at the Leerink Partners Healthcare Conference?

Silence Therapeutics will present on Wednesday, March 12th at 1:00 p.m. ET.

How can investors watch Silence Therapeutics' (SLN) Leerink conference presentation?

Investors can watch the live webcast through the Investors section at www.silence-therapeutics.com, with a replay available after the event.

What type of therapies does Silence Therapeutics (SLN) develop?

Silence Therapeutics develops siRNA (short interfering RNA) therapies and is currently in the clinical-stage phase.

Will Silence Therapeutics' (SLN) Leerink presentation be available for replay?

Yes, an archived replay of the webcast will be available on Silence Therapeutics' website following the conference.